Listed

enGene Therapeutics Inc.

ENGNNasdaqCIK 1980845HealthcareFiscal year ends Oct 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$34.0m, Q3 FY2026
Net income−$32.5m, Q3 FY2026
Line itemUnitQ4 FY20232023-10-31Q1 FY20242024-01-31Q2 FY20242024-04-30Q3 FY20242024-07-31Q4 FY20242024-10-31Q1 FY20252025-01-31Q2 FY20252025-04-30Q3 FY20252025-07-31Q4 FY20252025-10-31Q1 FY20262026-01-31Q2 FY20262026-04-30Q3 FY20262026-07-31
Research and development$m5.7Research and development, Q4 FY2023, three months to 2023-10-31$5.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2024-12-19, accession 0000950170-24-138472. Derived: 12-month figure less the 9-month figure.Report this figure5.6Research and development, Q1 FY2024, three months to 2024-01-31$5.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-03-10, accession 0000950170-25-036281.Report this figure9.9Research and development, Q2 FY2024, three months to 2024-04-30$9.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-06-12, accession 0000950170-25-085143.Report this figure11.5Research and development, Q3 FY2024, three months to 2024-07-31$11.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure11.3Research and development, Q4 FY2024, three months to 2024-10-31$11.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-12-22, accession 0001193125-25-328743. Derived: 12-month figure less the 9-month figure.Report this figure20.0Research and development, Q1 FY2025, three months to 2025-01-31$20.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure20.2Research and development, Q2 FY2025, three months to 2025-04-30$20.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure22.6Research and development, Q3 FY2025, three months to 2025-07-31$22.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure31.7Research and development, Q4 FY2025, three months to 2025-10-31$31.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-12-22, accession 0001193125-25-328743. Derived: 12-month figure less the 9-month figure.Report this figure22.3Research and development, Q1 FY2026, three months to 2026-01-31$22.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure22.2Research and development, Q2 FY2026, three months to 2026-04-30$22.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure20.1Research and development, Q3 FY2026, three months to 2026-07-31$20.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure
Operating income$m(10.4)Operating income, Q4 FY2023, three months to 2023-10-31−$10.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-12-19, accession 0000950170-24-138472. Derived: 12-month figure less the 9-month figure.Report this figure(10.8)Operating income, Q1 FY2024, three months to 2024-01-31−$10.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-03-10, accession 0000950170-25-036281.Report this figure(17.3)Operating income, Q2 FY2024, three months to 2024-04-30−$17.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-06-12, accession 0000950170-25-085143.Report this figure(16.8)Operating income, Q3 FY2024, three months to 2024-07-31−$16.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure(17.5)Operating income, Q4 FY2024, three months to 2024-10-31−$17.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-12-22, accession 0001193125-25-328743. Derived: 12-month figure less the 9-month figure.Report this figure(26.6)Operating income, Q1 FY2025, three months to 2025-01-31−$26.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure(27.1)Operating income, Q2 FY2025, three months to 2025-04-30−$27.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure(29.9)Operating income, Q3 FY2025, three months to 2025-07-31−$29.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure(39.5)Operating income, Q4 FY2025, three months to 2025-10-31−$39.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-12-22, accession 0001193125-25-328743. Derived: 12-month figure less the 9-month figure.Report this figure(31.2)Operating income, Q1 FY2026, three months to 2026-01-31−$31.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure(32.0)Operating income, Q2 FY2026, three months to 2026-04-30−$32.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure(34.0)Operating income, Q3 FY2026, three months to 2026-07-31−$34.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure
Interest expense$m1.2Interest expense, Q4 FY2023, three months to 2023-10-31$1.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-01-29, accession 0000950170-24-008125. Derived: 12-month figure less the 9-month figure.Report this figure0.6Interest expense, Q1 FY2024, three months to 2024-01-31$563.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-03-11, accession 0000950170-24-029413.Report this figure0.7Interest expense, Q2 FY2024, three months to 2024-04-30$728.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-06-14, accession 0000950170-24-073330.Report this figure0.8Interest expense, Q3 FY2024, three months to 2024-07-31$751.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure0.8Interest expense, Q4 FY2024, three months to 2024-10-31$756.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-12-22, accession 0001193125-25-328743. Derived: 12-month figure less the 9-month figure.Report this figure0.8Interest expense, Q1 FY2025, three months to 2025-01-31$752.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure0.7Interest expense, Q2 FY2025, three months to 2025-04-30$734.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure0.8Interest expense, Q3 FY2025, three months to 2025-07-31$758.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure0.8Interest expense, Q4 FY2025, three months to 2025-10-31$750.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-12-22, accession 0001193125-25-328743. Derived: 12-month figure less the 9-month figure.Report this figure0.7Interest expense, Q1 FY2026, three months to 2026-01-31$732.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure0.7Interest expense, Q2 FY2026, three months to 2026-04-30$745.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure0.8Interest expense, Q3 FY2026, three months to 2026-07-31$843.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure
Income tax$m0.0Income tax, Q4 FY2023, three months to 2023-10-31$17.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2024-12-19, accession 0000950170-24-138472. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Income tax, Q1 FY2024, three months to 2024-01-31−$30.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-03-10, accession 0000950170-25-036281.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-04-30$21.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-06-12, accession 0000950170-25-085143.Report this figure(0.0)Income tax, Q3 FY2024, three months to 2024-07-31−$29.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-10-31$19.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-12-22, accession 0001193125-25-328743. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-01-31$18.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure0.2Income tax, Q2 FY2025, three months to 2025-04-30$240.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure0.2Income tax, Q3 FY2025, three months to 2025-07-31$239.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure(0.5)Income tax, Q4 FY2025, three months to 2025-10-31−$497.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-12-22, accession 0001193125-25-328743. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-01-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-04-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure0.0Income tax, Q3 FY2026, three months to 2026-07-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure
Net income$m(82.5)Net income, Q4 FY2023, three months to 2023-10-31−$82.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-12-19, accession 0000950170-24-138472. Derived: 12-month figure less the 9-month figure.Report this figure(10.7)Net income, Q1 FY2024, three months to 2024-01-31−$10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure(15.0)Net income, Q2 FY2024, three months to 2024-04-30−$15.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure(14.1)Net income, Q3 FY2024, three months to 2024-07-31−$14.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure(15.3)Net income, Q4 FY2024, three months to 2024-10-31−$15.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-12-22, accession 0001193125-25-328743. Derived: 12-month figure less the 9-month figure.Report this figure(24.6)Net income, Q1 FY2025, three months to 2025-01-31−$24.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure(25.8)Net income, Q2 FY2025, three months to 2025-04-30−$25.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure(29.0)Net income, Q3 FY2025, three months to 2025-07-31−$29.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure(37.9)Net income, Q4 FY2025, three months to 2025-10-31−$37.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-12-22, accession 0001193125-25-328743. Derived: 12-month figure less the 9-month figure.Report this figure(29.8)Net income, Q1 FY2026, three months to 2026-01-31−$29.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure(30.2)Net income, Q2 FY2026, three months to 2026-04-30−$30.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure(32.5)Net income, Q3 FY2026, three months to 2026-07-31−$32.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure
Diluted EPS$ per sharenot reported0.46Diluted EPS, Q1 FY2024, three months to 2024-01-31$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-03-10, accession 0000950170-25-036281.Report this figure0.38Diluted EPS, Q2 FY2024, three months to 2024-04-30$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-06-12, accession 0000950170-25-085143.Report this figure0.32Diluted EPS, Q3 FY2024, three months to 2024-07-31$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figurenot reported0.48Diluted EPS, Q1 FY2025, three months to 2025-01-31$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure(0.51)Diluted EPS, Q2 FY2025, three months to 2025-04-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure(0.57)Diluted EPS, Q3 FY2025, three months to 2025-07-31−$0.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figurenot reported0.44Diluted EPS, Q1 FY2026, three months to 2026-01-31$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure(0.43)Diluted EPS, Q2 FY2026, three months to 2026-04-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure(0.47)Diluted EPS, Q3 FY2026, three months to 2026-07-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure
Basic EPS$ per sharenot reported0.46Basic EPS, Q1 FY2024, three months to 2024-01-31$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-03-10, accession 0000950170-25-036281.Report this figure0.38Basic EPS, Q2 FY2024, three months to 2024-04-30$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-06-12, accession 0000950170-25-085143.Report this figure0.32Basic EPS, Q3 FY2024, three months to 2024-07-31$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figurenot reported0.48Basic EPS, Q1 FY2025, three months to 2025-01-31$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure(0.51)Basic EPS, Q2 FY2025, three months to 2025-04-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure(0.57)Basic EPS, Q3 FY2025, three months to 2025-07-31−$0.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figurenot reported0.44Basic EPS, Q1 FY2026, three months to 2026-01-31$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure(0.43)Basic EPS, Q2 FY2026, three months to 2026-04-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure(0.47)Basic EPS, Q3 FY2026, three months to 2026-07-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure

Balance sheet

Cash and equivalents$41.0m, Q3 FY2026
Shareholders' equity$230.3m, Q3 FY2026
Line itemUnitFY20232023-10-31Q1 FY20242024-01-31Q2 FY20242024-04-30Q3 FY20242024-07-31FY20242024-10-31Q1 FY20252025-01-31Q2 FY20252025-04-30Q3 FY20252025-07-31FY20252025-10-31Q1 FY20262026-01-31Q2 FY20262026-04-30Q3 FY20262026-07-31
Cash and equivalents$m81.5Cash and equivalents, FY2023, at 2023-10-31$81.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2024-12-19, accession 0000950170-24-138472.Report this figure85.6Cash and equivalents, Q1 FY2024, at 2024-01-31$85.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-03-11, accession 0000950170-24-029413.Report this figure265Cash and equivalents, Q2 FY2024, at 2024-04-30$264.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-06-14, accession 0000950170-24-073330.Report this figure258Cash and equivalents, Q3 FY2024, at 2024-07-31$257.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-09-10, accession 0000950170-24-105180.Report this figure173Cash and equivalents, FY2024, at 2024-10-31$173.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-12-22, accession 0001193125-25-328743.Report this figure62.3Cash and equivalents, Q1 FY2025, at 2025-01-31$62.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-03-10, accession 0000950170-25-036281.Report this figure57.5Cash and equivalents, Q2 FY2025, at 2025-04-30$57.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-06-12, accession 0000950170-25-085143.Report this figure32.6Cash and equivalents, Q3 FY2025, at 2025-07-31$32.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure50.2Cash and equivalents, FY2025, at 2025-10-31$50.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure36.6Cash and equivalents, Q1 FY2026, at 2026-01-31$36.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure29.8Cash and equivalents, Q2 FY2026, at 2026-04-30$29.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure41.0Cash and equivalents, Q3 FY2026, at 2026-07-31$41.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure
Current assets$m85.4Current assets, FY2023, at 2023-10-31$85.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2024-12-19, accession 0000950170-24-138472.Report this figure89.6Current assets, Q1 FY2024, at 2024-01-31$89.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-03-11, accession 0000950170-24-029413.Report this figure270Current assets, Q2 FY2024, at 2024-04-30$269.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-06-14, accession 0000950170-24-073330.Report this figure263Current assets, Q3 FY2024, at 2024-07-31$262.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-09-10, accession 0000950170-24-105180.Report this figure247Current assets, FY2024, at 2024-10-31$247.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-12-22, accession 0001193125-25-328743.Report this figure222Current assets, Q1 FY2025, at 2025-01-31$222.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-03-10, accession 0000950170-25-036281.Report this figure228Current assets, Q2 FY2025, at 2025-04-30$228.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-06-12, accession 0000950170-25-085143.Report this figure211Current assets, Q3 FY2025, at 2025-07-31$211.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure201Current assets, FY2025, at 2025-10-31$201.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure289Current assets, Q1 FY2026, at 2026-01-31$289.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure270Current assets, Q2 FY2026, at 2026-04-30$270.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure278Current assets, Q3 FY2026, at 2026-07-31$277.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure
Total assets$m87.0Total assets, FY2023, at 2023-10-31$87.0m. XBRL concept us-gaap:Assets. 10-K filed 2024-12-19, accession 0000950170-24-138472.Report this figure93.4Total assets, Q1 FY2024, at 2024-01-31$93.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-03-11, accession 0000950170-24-029413.Report this figure274Total assets, Q2 FY2024, at 2024-04-30$273.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-06-14, accession 0000950170-24-073330.Report this figure267Total assets, Q3 FY2024, at 2024-07-31$266.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-09-10, accession 0000950170-24-105180.Report this figure311Total assets, FY2024, at 2024-10-31$311.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-12-22, accession 0001193125-25-328743.Report this figure286Total assets, Q1 FY2025, at 2025-01-31$285.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-03-10, accession 0000950170-25-036281.Report this figure267Total assets, Q2 FY2025, at 2025-04-30$266.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-06-12, accession 0000950170-25-085143.Report this figure246Total assets, Q3 FY2025, at 2025-07-31$245.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure221Total assets, FY2025, at 2025-10-31$221.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure337Total assets, Q1 FY2026, at 2026-01-31$337.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure308Total assets, Q2 FY2026, at 2026-04-30$307.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure288Total assets, Q3 FY2026, at 2026-07-31$288.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure
Current liabilities$m5.3Current liabilities, FY2023, at 2023-10-31$5.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2024-12-19, accession 0000950170-24-138472.Report this figure6.9Current liabilities, Q1 FY2024, at 2024-01-31$6.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-03-11, accession 0000950170-24-029413.Report this figure6.3Current liabilities, Q2 FY2024, at 2024-04-30$6.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-06-14, accession 0000950170-24-073330.Report this figure13.5Current liabilities, Q3 FY2024, at 2024-07-31$13.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-09-10, accession 0000950170-24-105180.Report this figure14.7Current liabilities, FY2024, at 2024-10-31$14.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-12-22, accession 0001193125-25-328743.Report this figure13.0Current liabilities, Q1 FY2025, at 2025-01-31$13.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-03-10, accession 0000950170-25-036281.Report this figure18.0Current liabilities, Q2 FY2025, at 2025-04-30$18.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-06-12, accession 0000950170-25-085143.Report this figure20.4Current liabilities, Q3 FY2025, at 2025-07-31$20.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure32.0Current liabilities, FY2025, at 2025-10-31$32.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure24.6Current liabilities, Q1 FY2026, at 2026-01-31$24.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure21.5Current liabilities, Q2 FY2026, at 2026-04-30$21.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure27.2Current liabilities, Q3 FY2026, at 2026-07-31$27.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure
Total liabilities$m14.5Total liabilities, FY2023, at 2023-10-31$14.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2024-12-19, accession 0000950170-24-138472.Report this figure31.0Total liabilities, Q1 FY2024, at 2024-01-31$31.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-03-11, accession 0000950170-24-029413.Report this figure30.6Total liabilities, Q2 FY2024, at 2024-04-30$30.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-06-14, accession 0000950170-24-073330.Report this figure36.6Total liabilities, Q3 FY2024, at 2024-07-31$36.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-09-10, accession 0000950170-24-105180.Report this figure38.6Total liabilities, FY2024, at 2024-10-31$38.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-12-22, accession 0001193125-25-328743.Report this figure36.0Total liabilities, Q1 FY2025, at 2025-01-31$36.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-03-10, accession 0000950170-25-036281.Report this figure39.4Total liabilities, Q2 FY2025, at 2025-04-30$39.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-06-12, accession 0000950170-25-085143.Report this figure44.9Total liabilities, Q3 FY2025, at 2025-07-31$44.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure53.8Total liabilities, FY2025, at 2025-10-31$53.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure55.6Total liabilities, Q1 FY2026, at 2026-01-31$55.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure52.4Total liabilities, Q2 FY2026, at 2026-04-30$52.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure58.0Total liabilities, Q3 FY2026, at 2026-07-31$58.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure
Shareholders' equity$m72.5Shareholders' equity, FY2023, at 2023-10-31$72.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-12-22, accession 0001193125-25-328743.Report this figure62.4Shareholders' equity, Q1 FY2024, at 2024-01-31$62.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure243Shareholders' equity, Q2 FY2024, at 2024-04-30$243.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure230Shareholders' equity, Q3 FY2024, at 2024-07-31$230.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure273Shareholders' equity, FY2024, at 2024-10-31$272.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure250Shareholders' equity, Q1 FY2025, at 2025-01-31$249.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure227Shareholders' equity, Q2 FY2025, at 2025-04-30$227.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure201Shareholders' equity, Q3 FY2025, at 2025-07-31$200.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure168Shareholders' equity, FY2025, at 2025-10-31$167.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure282Shareholders' equity, Q1 FY2026, at 2026-01-31$281.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure255Shareholders' equity, Q2 FY2026, at 2026-04-30$255.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure230Shareholders' equity, Q3 FY2026, at 2026-07-31$230.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure

Cash flow

Operating cash flow−$18.9m, Q3 FY2026
Capital expenditure$0, Q3 FY2026
Line itemUnitQ4 FY20232023-10-31Q1 FY20242024-01-31Q2 FY20242024-04-30Q3 FY20242024-07-31Q4 FY20242024-10-31Q1 FY20252025-01-31Q2 FY20252025-04-30Q3 FY20252025-07-31Q4 FY20252025-10-31Q1 FY20262026-01-31Q2 FY20262026-04-30Q3 FY20262026-07-31
Operating cash flow$m(6.8)Operating cash flow, Q4 FY2023, three months to 2023-10-31−$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-12-19, accession 0000950170-24-138472. Derived: 12-month figure less the 9-month figure.Report this figure(7.4)Operating cash flow, Q1 FY2024, three months to 2024-01-31−$7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-03-10, accession 0000950170-25-036281.Report this figure(14.2)Operating cash flow, Q2 FY2024, three months to 2024-04-30−$14.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-06-12, accession 0000950170-25-085143. Derived: 6-month figure less the 3-month figure.Report this figure(7.2)Operating cash flow, Q3 FY2024, three months to 2024-07-31−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-09-11, accession 0000950170-25-114224. Derived: 9-month figure less the 6-month figure.Report this figure(19.6)Operating cash flow, Q4 FY2024, three months to 2024-10-31−$19.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-12-22, accession 0001193125-25-328743. Derived: 12-month figure less the 9-month figure.Report this figure(25.7)Operating cash flow, Q1 FY2025, three months to 2025-01-31−$25.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure(22.9)Operating cash flow, Q2 FY2025, three months to 2025-04-30−$22.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-06-15, accession 0001193125-26-270386. Derived: 6-month figure less the 3-month figure.Report this figure(25.6)Operating cash flow, Q3 FY2025, three months to 2025-07-31−$25.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-09-08, accession 0001193125-26-384383. Derived: 9-month figure less the 6-month figure.Report this figure(25.0)Operating cash flow, Q4 FY2025, three months to 2025-10-31−$25.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-12-22, accession 0001193125-25-328743. Derived: 12-month figure less the 9-month figure.Report this figure(28.9)Operating cash flow, Q1 FY2026, three months to 2026-01-31−$28.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure(30.5)Operating cash flow, Q2 FY2026, three months to 2026-04-30−$30.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-06-15, accession 0001193125-26-270386. Derived: 6-month figure less the 3-month figure.Report this figure(18.9)Operating cash flow, Q3 FY2026, three months to 2026-07-31−$18.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-09-08, accession 0001193125-26-384383. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q4 FY2023, three months to 2023-10-31$138.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-12-19, accession 0000950170-24-138472. Derived: 12-month figure less the 9-month figure.Report this figure0.5Capital expenditure, Q1 FY2024, three months to 2024-01-31$506.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-03-10, accession 0000950170-25-036281.Report this figure0.2Capital expenditure, Q2 FY2024, three months to 2024-04-30$179.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-06-12, accession 0000950170-25-085143. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-07-31$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-09-11, accession 0000950170-25-114224. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-10-31$238.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-12-22, accession 0001193125-25-328743. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2025, three months to 2025-01-31$299.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-04-30$45.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-06-15, accession 0001193125-26-270386. Derived: 6-month figure less the 3-month figure.Report this figure0.7Capital expenditure, Q3 FY2025, three months to 2025-07-31$704.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-09-08, accession 0001193125-26-384383. Derived: 9-month figure less the 6-month figure.Report this figure0.4Capital expenditure, Q4 FY2025, three months to 2025-10-31$437.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-12-22, accession 0001193125-25-328743. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2026, three months to 2026-01-31$153.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-04-30$98.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-06-15, accession 0001193125-26-270386. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2026, three months to 2026-07-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-09-08, accession 0001193125-26-384383. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)69.73m, Q3 FY2026
Line itemUnitperiod not labelled2023-01-31period not labelled2023-04-30period not labelled2023-07-31Q1 FY20242024-01-31Q2 FY20242024-04-30Q3 FY20242024-07-31Q1 FY20252025-01-31Q2 FY20252025-04-30Q3 FY20252025-07-31Q1 FY20262026-01-31Q2 FY20262026-04-30Q3 FY20262026-07-31
Diluted shares (weighted)m shares0.7Diluted shares (weighted), period not labelled, three months to 2023-01-31651,074 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-03-11, accession 0000950170-24-029413.Report this figure0.7Diluted shares (weighted), period not labelled, three months to 2023-04-30694,497 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-06-14, accession 0000950170-24-073330.Report this figure0.7Diluted shares (weighted), period not labelled, three months to 2023-07-31701,323 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-09-10, accession 0000950170-24-105180.Report this figure23.2Diluted shares (weighted), Q1 FY2024, three months to 2024-01-3123,197,976 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-03-10, accession 0000950170-25-036281.Report this figure39.4Diluted shares (weighted), Q2 FY2024, three months to 2024-04-3039,443,768 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-06-12, accession 0000950170-25-085143.Report this figure44.2Diluted shares (weighted), Q3 FY2024, three months to 2024-07-3144,168,986 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-09-11, accession 0000950170-25-114224.Report this figure51.0Diluted shares (weighted), Q1 FY2025, three months to 2025-01-3150,976,958 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure51.0Diluted shares (weighted), Q2 FY2025, three months to 2025-04-3051,019,363 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure51.1Diluted shares (weighted), Q3 FY2025, three months to 2025-07-3151,097,711 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure67.3Diluted shares (weighted), Q1 FY2026, three months to 2026-01-3167,263,234 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-03-09, accession 0001193125-26-097541.Report this figure69.7Diluted shares (weighted), Q2 FY2026, three months to 2026-04-3069,724,761 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-06-15, accession 0001193125-26-270386.Report this figure69.7Diluted shares (weighted), Q3 FY2026, three months to 2026-07-3169,734,610 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure

Shares outstanding: 67.02mShares outstanding, period not labelled, at 2026-09-0267,016,316 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-09-08, accession 0001193125-26-384383.Report this figure at Sep 2, 2026, from the cover of the 10-Q filed Sep 8, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.